Drugs / Sophora flavescens Aiton
Sophora flavescens Aiton
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06850311 | Mar 2025 → Mar 2027 expected | atopic eczema, hereditary skin disorder | En Chu Kong Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sophora flavescens Aiton | “In human trial, 66 Subjects diagnosed as AD will be enrolled and treated with Sophora flavescens Aiton topical ointment.” NCT06850311 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “new topical application of traditional Chinese medicine” NCT06850311 ↗ |
| Route | Topical | “new topical application of traditional Chinese medicine” NCT06850311 ↗ |